Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2015 | $1,150,515 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2015 | $13,628,726 | | tax credit/rebate |
Intervet, Inc. | Merck | Delaware | state | 2015 | $29,352 | | training reimbursement |
Amgen, Inc. | Amgen | Maryland | state | 2015 | $211,236 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2015 | $210,178 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2015 | $1,019 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2015 | $209,811 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2015 | $1,264,635 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2015 | $11,699 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Maryland | state | 2015 | $5,767 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2015 | $91,536 | | tax credit/rebate |
Pfizer Inc., and Subsidiaries | Pfizer | Maryland | state | 2015 | $427,891 | | tax credit/rebate |
Teva Biopharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2015 | $53,885 | | tax credit/rebate |
United Therapeutics Corporation and Subsidiaries | United Therapeutics | Maryland | state | 2015 | $72,866 | | tax credit/rebate |
BOEHRINGER INGELHEIM USA | Boehringer Ingelheim | Missouri | state | 2015 | $13,879 | | tax credit/rebate |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2015 | $95,771 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2015 | $4,151,414 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2015 | $4,151,414 | | enterprise zone |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2015 | $34,827 | | enterprise zone |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2015 | $1,330,020 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2015 | $3,701,242 | | tax credit/rebate |
Akorn, Inc. | Akorn Inc. | Illinois | state | 2015 | $596,900 | | tax credit/rebate |
Synageva BioPharma Corp | AstraZeneca | Massachusetts | state | 2015 | $900,000 | | tax credit/rebate |
Shire Human Genetic Therapies | Takeda Pharmaceutical | Massachusetts | state | 2015 | $985,000 | | tax credit/rebate |
Biogen Idec, MA Inc. | Biogen | Massachusetts | state | 2015 | $1,440,000 | | tax credit/rebate |
Amgen Inc. | Amgen | Massachusetts | state | 2015 | $1,800,000 | | tax credit/rebate |
Merrimack Pharmaceuticals, Inc. | Merrimack Pharmaceuticals | Massachusetts | state | 2015 | $1,350,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2015 | $1,800,000 | | tax credit/rebate |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | Florida | state | 2015 | undisclosed | | tax credit/rebate |
Elanco Us Inc. | Elanco Animal Health | Iowa | state | 2015 | $684,174 | | training reimbursement |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2015 | $83,656 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2015 | $404,026 | | tax credit/rebate |
Merck | Merck | Virginia | state | 2015 | $1,500,000 | | grant |
Mylan Inc | Viatris | West Virginia | state | 2015 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2015 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2015 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2015 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2015 | undisclosed | | tax credit/rebate |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $1,050,000 | | tax credit/rebate |
Ultragenyx Pharmaceutical, Inc. | Ultragenyx Pharmaceutical | California | state | 2014 | $2,100,000 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. | Novartis | California | state | 2014 | $1,000,000 | | tax credit/rebate |
Megadyne Medical Products, Inc. | Johnson & Johnson | United States | federal | 2014 | | $3,375,000 | federal loan or loan guarantee |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2014 | $58,245 | | property tax abatement |
IDEXX LAB INC | IDEXX Laboratories | Maine | state | 2014 | $37,045 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2014 | $13,652 | | property tax abatement |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2014 | $3,832 | | property tax abatement |
IDEXX DISTRIBUTION INC | IDEXX Laboratories | Maine | state | 2014 | $1,144 | | property tax abatement |
APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2014 | $159,943 | | grant |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2014 | $23,200 | | grant |
Cambridge Major Laboratories, Inc. | Alcami | Wisconsin | state | 2014 | $800,000 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2014 | $1,480 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2014 | $5,264 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2014 | $1,497,096 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2014 | $39,722 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2014 | $60,651 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2014 | $50,617 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Maryland | state | 2014 | $74,558 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Maryland | state | 2014 | $8,737 | | tax credit/rebate |
Emergent Biosolutions Inc. | Emergent BioSolutions | Maryland | state | 2014 | $103,503 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2014 | $80,651 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2014 | $59,756 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2014 | $50,570 | | tax credit/rebate |
United Therapeutics Corporation & Subs. | United Therapeutics | Maryland | state | 2014 | $42,268 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica Inc. | Eli Lilly | Iowa | state | 2014 | $506,133 | | tax credit/rebate |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Kansas | state | 2014 | $3,861,454 | | grant |
Novartis Vaccines & Diagnostics, Inc | Novartis | North Carolina | state | 2014 | $653,000 | | grant |
Novartis Vaccines & Diagnostics, Inc | Novartis | North Carolina | state | 2014 | $347,000 | | grant |
MYLAN TECHNOLOGIES | Viatris | Vermont | state | 2014 | $206,180 | | training reimbursement |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | Florida | state | 2014 | $2,779,200 | | tax credit/rebate |
Lupin, Inc. | Lupin Limited | Florida | state | 2014 | $252,000 | | tax credit/rebate |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | Florida | state | 2014 | $3,500,000 | | grant |
Johnson and Johnson Vision Care, Inc. | Johnson & Johnson | Florida | state | 2014 | $1,300,000 | | grant |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $200,000 | | training reimbursement |
Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | Kentucky | state | 2014 | $25,000 | | training reimbursement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2014 | $522,063 | | property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2014 | $822,257 | | property tax abatement |
BOEHRINGER INGELHEIM VETMEDICA, INC. | Eli Lilly | Missouri | state | 2014 | $273,219 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2014 | $3,476,438 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2014 | $645,884 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2014 | $185,492 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $97,337 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2014 | $59,897 | | tax credit/rebate |
AAIPharma Services Corp. | Alcami | North Carolina | state | 2014 | $19,526 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2014 | $29,864 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $162,504 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2014 | $218,428 | | tax credit/rebate |
C3I | Merck | New Hampshire | state | 2014 | $9,576 | | training reimbursement |
Sandoz Inc. | Sandoz Group | New Jersey | state | 2014 | $9,180,000 | | tax credit/rebate |
Johnson & Johnson Health Care Systems | Johnson & Johnson | Tennessee | local | 2014 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2014 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2014 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2014 | undisclosed | | property tax abatement |
Pfizer, Inc. | Pfizer | Tennessee | local | 2014 | undisclosed | | property tax abatement |
PHARMAVITE LLC | Otsuka Pharmaceutical | California | state | 2014 | $17,618 | | training reimbursement |
BOEHRINGER INGELHEIM FREMONT, INC. | Boehringer Ingelheim | California | state | 2014 | $248,794 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2014 | $344,534 | | training reimbursement |
Zoetis, LLC | Zoetis | Nebraska | state | 2014 | undisclosed | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2014 | $253,035 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2014 | $143,193 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2014 | $126,863 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2014 | $117,680 | | tax credit/rebate |